[Perioperative management for surgery against lung cancer in patients with receiving coronary stent implantation].
Increasing in patients with cardiac disease, it is estimated that the patients with receiving coronary artery stents implantation occur frequently at the time of surgery against lung cancer. However, the anti-thrombotic therapy in perioperative period is not well established. We reviewed the medical records of 934 patients who underwent pulmonary resection for primary lung cancer in our institute from March 1997 to November 2014. The cardiac disease was observed 101 patients, including 9 patients were implanted bare-metal stents( BMS) and 6 patients were done drug-eluting stents( DES). The interval to surgery after stent implantation was almost over 1-month in BMS-group (median:18 months) and more than 1-year in DES-group( median:22.5 months). The anti-thrombotic therapy was interrupted less than 14-days in almost cases. The patients with receiving coronary artery stents implantation expected to be increased more in future, perioperative anti-thrombotic management protocols must be established.